Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-01
2011-11-15
Shiao, Rei-tsang (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S541000
Reexamination Certificate
active
08058304
ABSTRACT:
Merged compounds of ion channel modulating compounds, including, for example, merged compounds of the ion channel modulating compound of the following formula: (I) are described herein, as well as methods of making and using such merged compounds and pharmaceutical compositions containing such merged compounds.
REFERENCES:
patent: 2954380 (1960-09-01), Shapiro et al.
patent: 3218328 (1965-11-01), Shapiro et al.
patent: 4145435 (1979-03-01), Szmuszkovicz
patent: 4179501 (1979-12-01), Szmuszkovicz
patent: 4188403 (1980-02-01), Orth et al.
patent: 4598087 (1986-07-01), Horwell
patent: 4656182 (1987-04-01), Horwell
patent: 4663343 (1987-05-01), Horwell et al.
patent: 4855316 (1989-08-01), Horwell et al.
patent: 4880800 (1989-11-01), Wallis et al.
patent: 4906655 (1990-03-01), Horwell et al.
patent: 5019588 (1991-05-01), Horwell et al.
patent: 5051428 (1991-09-01), Horwell et al.
patent: 5059620 (1991-10-01), Stout et al.
patent: 5492825 (1996-02-01), Jan et al.
patent: 5506257 (1996-04-01), MacLeod et al.
patent: 5637583 (1997-06-01), MacLeod et al.
patent: 5670335 (1997-09-01), Jan et al.
patent: 5728535 (1998-03-01), Lester et al.
patent: 5734021 (1998-03-01), Lester et al.
patent: 5750537 (1998-05-01), Nomura et al.
patent: 5817698 (1998-10-01), Brown et al.
patent: 5885984 (1999-03-01), MacLeod et al.
patent: 6174879 (2001-01-01), MacLeod et al.
patent: 6180632 (2001-01-01), Myers et al.
patent: 6210809 (2001-04-01), Okutomi et al.
patent: 6214810 (2001-04-01), Fermini et al.
patent: 6451819 (2002-09-01), Alanine et al.
patent: 6521619 (2003-02-01), Link et al.
patent: 6649603 (2003-11-01), Sum
patent: 6979685 (2005-12-01), Beatch et al.
patent: 7053087 (2006-05-01), Beatch et al.
patent: 7057053 (2006-06-01), Beatch et al.
patent: 7101877 (2006-09-01), Bain et al.
patent: 7259184 (2007-08-01), Beatch et al.
patent: 7345086 (2008-03-01), Beatch et al.
patent: 7345087 (2008-03-01), Beatch et al.
patent: 7507545 (2009-03-01), Fedida et al.
patent: 7524879 (2009-04-01), Beatch et al.
patent: 7534790 (2009-05-01), Bain et al.
patent: 7875611 (2011-01-01), Bain et al.
patent: 2005/0002693 (2005-01-01), Pak et al.
patent: 2005/0038256 (2005-02-01), Barrett et al.
patent: 2005/0070552 (2005-03-01), Fedida et al.
patent: 2006/0252753 (2006-11-01), Beatch et al.
patent: 2007/0099983 (2007-05-01), Barrett et al.
patent: 2007/0190156 (2007-08-01), Beatch et al.
patent: 2007/0197632 (2007-08-01), Beatch et al.
patent: 2007/0254945 (2007-11-01), Jung et al.
patent: 2009/0105256 (2009-04-01), Choi et al.
patent: 2010/0056603 (2010-03-01), Beatch et al.
patent: 1234808 (1988-04-01), None
patent: 1235122 (1988-04-01), None
patent: 1243020 (1988-10-01), None
patent: 2004575 (1990-06-01), None
patent: 2058502 (1993-06-01), None
patent: 2172513 (1995-03-01), None
patent: 2244209 (1997-07-01), None
patent: 2008391 (1997-12-01), None
patent: 2289055 (1999-01-01), None
patent: 2268590 (2000-10-01), None
patent: 2132841 (2001-03-01), None
patent: 2 259 260 (1974-06-01), None
patent: 2 658 401 (1978-07-01), None
patent: 3 517 901 (1985-12-01), None
patent: 222533 (1987-05-01), None
patent: 147085 (1990-03-01), None
patent: 372466 (1990-06-01), None
patent: 380063 (1990-08-01), None
patent: 0 546 583 (1993-06-01), None
patent: 552386 (1993-07-01), None
patent: 720605 (1996-07-01), None
patent: 215963 (1995-02-01), None
patent: 02-270864 (1990-11-01), None
patent: WO 93/19056 (1993-09-01), None
patent: WO 94/07843 (1994-04-01), None
patent: WO 94/14435 (1994-07-01), None
patent: WO 95/08544 (1995-03-01), None
patent: WO 95/28155 (1995-10-01), None
patent: WO 96/18615 (1996-06-01), None
patent: WO 96/23894 (1996-08-01), None
patent: WO 97/32857 (1997-09-01), None
patent: WO 97/49680 (1997-12-01), None
patent: WO 98/40055 (1998-09-01), None
patent: WO 99/02159 (1999-01-01), None
patent: WO 99/03468 (1999-01-01), None
patent: WO 99/11252 (1999-03-01), None
patent: WO 99/16431 (1999-04-01), None
patent: WO 99/50205 (1999-10-01), None
patent: WO 99/50225 (1999-10-01), None
patent: WO 00/23023 (2000-04-01), None
patent: WO 00/47547 (2000-08-01), None
patent: WO 00/51981 (2000-09-01), None
patent: WO 01/51474 (2001-07-01), None
patent: WO 01/96335 (2001-12-01), None
patent: WO 02/18334 (2002-03-01), None
patent: WO 03/105756 (2003-12-01), None
patent: WO 2004/008103 (2004-01-01), None
patent: WO 2004/098525 (2004-11-01), None
patent: WO 2004/099137 (2004-11-01), None
patent: WO 2005/018635 (2005-03-01), None
patent: WO 2005/094897 (2005-10-01), None
patent: WO 2005/113011 (2005-12-01), None
Billman et al.,2003, CAS: 139:270094.
Or Bain et al., 1999, CAS:131:257571.
Adcock et al., “RSD931, a novel anti-tussive agent acting on airway sensory nerves”,Br J Pharm138(3):407-416, 2003.
Altria et al., “Capillary Electrophoresis as a Routine Analytical Tool in Pharmaceutical Analysis”,LCGC19(9): 972-985, Sep. 2001.
Amin et al., “RPR 101821, a New Potent Cholesterol-lowering Agent: Inhibition of Squalene Synthase and 7-Dehydrocholesterol Reductase”,Naunyn-Schmiedeberg's Arch Pharmacol353:233-240, 1996.
Alzheimer's Disease Information Page [online], [retrieved on Oct. 3, 2006]. Retrieved from the Internet, URL: <http://www.ninds.nih.gov/disorders/alzheimersdisease/alzheimersdisease.htm>.
Asensio et al., “Epoxidation of Primary and Secondary Alkenylammonium Salts with Dimethyldioxirane, Methyl(trifluoromethyl)dioxirane, andm-Chloroperbenzoic Acid. A General Synthetic Route to Epoxyalkylamines”,J. Org. Chem. 60(12): 3692-3699, 1995.
Bain et al., “Better Antiarrhythmics? Development of Antiarrhythmic Drugs Selective for Ischaemia-Dependent Arrhythmias”,Drug Development Research42:198-210, 1997.
Bakalarz-Jeziorna et al., “Synthesis of multifunctionalized phosphonic acid esters via opening of oxiranes and azetidinium salts with phosphoryl-substituted carbanions”,J. Chem. Soc., Perkin Trans. 1: 1086-1090, 2001.
Barrett and Walker, “Glibenclamide Possesses Transient, Ischaemia Selective Class III Antiarrhythmic Actions But Does Not Prevent Ischaemic Arrhythmias”,BPS Proceedings116P, 1996.
Barrett et al., “A Model of Myocardial Ischemia for the Simultaneous Assessment of Electrophysiological Changes and Arrhythmias in Intact Rabbits”,J Pharmacol Toxicol Methods37(1):27-36, 1997.
Barrett et al., “Ischaemia selectivity confers efficacy for suppression of ischaemia-induced arrhythmias in rats”,Eur J Pharm398:365-374, 2000.
Barrett et al., “Atypical Dose Response Curves for Antiarrhythmic Drugs”,BPS Proceedings115P, 1996.
Barrett, “Ischemia Selective Electrophysiological and Antiarrhythmic Actions of RSD1019 in Ischemic Cardiac Tissue”,J Mol Cell Cardiol29:197, 1997.
Barrett et al., “RSD1019 suppresses ischaemia-induced monophasic action potential shortening and arrhythmias in anaesthetized rabbits”,Br J Pharm131(3):405-414, 2000.
Beatch et al., “RSD1235 Selectively Prolongs Atrial Refractoriness and Terminates AF in Dogs with Electrically Remodelled Atria”,Pharmacologist44(2) (Supp I), A15: XIVthWorld Congress of Pharmacology: Meeting Abstracts, 2002. Abstract No. 22.11.
Beatch et al., “Effect of a Novel Anti-tussive Compound CP1 Against Citric Acid Induced Cough in Guinea-Pigs”,Proc West Pharmacol Soc44:252, 2001.
Beatch et al., “RSD1235 Rapidly and Effectively Terminates Atrial Fibrillation”, Abstract submission ESC Congress Aug. 30-Sep. 3, 2003, in Vienna, Austria.
Beatch et al., “RSD1235, A Novel Atrial-Selective Antiarrhythmic Drug, Shows Rapid and Extensive Oral Absorption in Man”, 12thInternational Congress on Cardiovascular Pharmacotherapy, May 7-10, 2003, Barcelona, Spain.
Beatch et al., “Ventricular Fibrillation, an Uncontrolled Arrhythmia Seeking New Targets”,Drug Develop Res55:45-52, 2002.
Beatch, “Antihistamine-induced Ventricular Arrhythmias”,BPS Proceedings120P, 1996.
Beatch et al., “Characterization of a Non-Human Primate Model of Drug-Induced Torsad
Choi Lewis S. L.
Chou Doug Ta Hung
Jung Grace
Plouvier Bertrand M. C.
Cardiome Pharma Corp.
Seed IP Law Group PLLC
Shiao Rei-tsang
LandOfFree
Merged ion channel modulating compounds and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Merged ion channel modulating compounds and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Merged ion channel modulating compounds and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4267853